Blueprint Medicines

Blueprint Medicines

Biotechnology Research

Cambridge, Massachusetts 48,234 followers

Striving to improve and extend patients' lives

Über uns

Blueprint Medicines is a global, fully integrated biopharmaceutical company that invents life-changing medicines. We seek to alleviate human suffering by solving important medical problems in two core focus areas: allergy/inflammation and oncology/hematology. Our approach begins by targeting the root causes of disease, using deep scientific knowledge in our core focus areas and drug discovery expertise across multiple therapeutic modalities. We have a proven track record of success with two approved medicines in the U.S. and Europe. Leveraging our established research, development, and commercial capability and infrastructure, we now aim to significantly scale our impact by advancing a broad pipeline of programs ranging from early science to advanced clinical trials in mast cell diseases including systemic mastocytosis and chronic urticaria, breast cancer and other solid tumors. Patients are at the center of our mission. We know that in order to make a difference in their lives, we must create an environment where our employees — also known as the Blue Crew — can do their best work. Our culture of transparency, curiosity and diversity empowers us to draw upon a wide range of backgrounds and perspectives to build a conscientious team dynamic. Ideas come from every member of the Blue Crew, from the executive team to new hires. Each day, our teams commit to approach one another with respect and trust: a simple promise that fosters an inclusive and collaborative spirit. We care deeply about the communities where we live and work, and we strive to make a profound impact where it matters most. Learn more about who we are and explore our career opportunities at https://www.blueprintmedicines.com/careers/. Read our community guidelines: https://www.blueprintmedicines.com/community-guidelines/.

Website
http://www.blueprintmedicines.com
Industrie
Biotechnology Research
Größe des Unternehmens
501-1,000 employees
Hauptsitz
Cambridge, Massachusetts
Typ
Öffentliches Unternehmen
Gegründet
2011
Spezialitäten
targeted therapy, systemic mastocytosis, breast cancer, allergy/inflammatory, hematology/oncology, solid tumors, drug design, and mast cell biology

Standorte

Employees at Blueprint Medicines

Aktualisierungen

Ähnliche Seiten

Jobs durchsuchen

Aktie

BPMC

NASDAQ

20 Minuten Verzögerung

$108.30

1.27 (1.187%)

Öffnen Sie
107.81
Niedrig
106.9
Hoch
110.21

Daten von Refinitiv

Siehe mehr Informationen auf Bing

Finanzierung

Blueprint Medicines 9 total rounds

Letzte Runde

Eigenkapital nach dem IPO

US$ 1.3B

Siehe mehr Informationen auf crunchbase